Twist Bioscience Revenue and Competitors

Location

$503.1M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Twist Bioscience's estimated annual revenue is currently $132.3M per year.(i)
  • Twist Bioscience received $50.0M in venture funding in April 2018.
  • Twist Bioscience's estimated revenue per employee is $125,550
  • Twist Bioscience's total funding is $503.1M.
  • Twist Bioscience's current valuation is $3B. (January 2022)

Employee Data

  • Twist Bioscience has 1054 Employees.(i)
  • Twist Bioscience grew their employee count by -3% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.8M95-12%$27.2MN/A
#2
$13.4M55N/AN/AN/A
#3
$1M12N/AN/AN/A
#4
$3.5M43N/AN/AN/A
#5
$24.9M156N/AN/AN/A
#6
$19.8M78-26%$1.4MN/A
#7
$3.3M28N/AN/AN/A
#8
$135M53511%$1.1BN/A
#9
$2.8M28N/AN/AN/A
#10
$76.3M436N/AN/AN/A
#11
$8.8M35N/AN/AN/A
#12
$1321M5263N/AN/AN/A
#13
$102.3M334N/AN/AN/A
Add Company

Twist Bioscience is a synthetic biology company based in San Francisco, California. The company has developed a proprietary silicon-based manufacturing process for the production of synthetic DNA. Twist Bioscience serves Life Science researchers who are changing the world for the better. Coming from diverse fields of medicine, agriculture, industrial chemicals and data storage, scientists use our synthetic genes, oligo pools, and NGS target enrichment to better lives and improve the sustainability of the planet. Twist Bioscience is uniquely positioned to help accelerate these efforts by providing precision at a scale that is otherwise unavailable. Our technology overcomes inefficiencies and enables cost-effective, rapid, precise, high-throughput DNA synthesis and sequencing. We offer both the quality and quantity researchers need now to rapidly realize opportunities ahead. Twitter @TwistBioscience Facebook facebook.com/TwistBioscience YouTube youtube.com/TwistBioscience #WeMakeDNA

keywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Wind Power

$503.1M

Total Funding

1054

Number of Employees

$132.3M

Revenue (est)

-3%

Employee Growth %

$3B

Valuation

N/A

Accelerator

Twist Bioscience's People

NameTitleEmail/Phone
1
Director, Protein Sciences and Cell BiologyReveal Email/Phone
2
CEO and Co-FounderReveal Email/Phone
3
SVP Advanced Development and GM Data StorageReveal Email/Phone
4
Director Business DevelopmentReveal Email/Phone
5
Senior RecruiterReveal Email/Phone
6
SynBio Account Manager | US Midwest & Central CanadaReveal Email/Phone
7
Office Administrator / EA to Aaron Sato, CSOReveal Email/Phone
8
Director Program ManagementReveal Email/Phone
9
Sr Manager, Commercial FinanceReveal Email/Phone
10
Senior Product ManagerReveal Email/Phone

Twist Bioscience News

2022-04-20 - Twist Bioscience Launches High Throughput Antibody ...

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform...

2022-04-13 - Twist Bioscience to Report Fiscal 2022 Second Quarter ...

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis...

2022-04-13 - Twist Bioscience to Become Voting Member of Storage ...

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis...

2021-03-22 - Twist Bioscience Functional GLP-1R Antibodies Identified From Its Proprietary Synthetic DNA GPCR Libraries Demonstrate Potent Blood Glucose Control

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mar 22, 2021-- Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced positive preclinical data demonstrating that GLP-1R an ...

2021-03-15 - Twist Bioscience Begins Shipping of Synthetic RNA Controls for B.1.351 and P.1 Variants

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mar 15, 2021-- Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has started shipping its new synthetic RNA ref ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$306.5M10544%N/A
#2
$427.1M1058-12%$15.2B
#3
$179M1060-8%$307.5M
#4
$328.4M10616%N/A
#5
$214.4M1071-1%$462M

Twist Bioscience Funding

DateAmountRoundLead InvestorsReference
2014-02-13$9.1MAArticle
2014-05-28$26.0MBTao InvestArticle
2014-10-01$10.0MUndisclosedSilicon Valley BankArticle
2015-06-11$37.0MCIllumina IncArticle
2016-01-20$61.0MDMultipleArticle
2017-03-28$33.0MUndisclosedArticle
2017-06-15$27.0MUndisclosedArticle
2018-04-03$50.0MUndisclosedArticle